270 related articles for article (PubMed ID: 34737297)
1. Hepatic expression of GAA results in enhanced enzyme bioavailability in mice and non-human primates.
Costa-Verdera H; Collaud F; Riling CR; Sellier P; Nordin JML; Preston GM; Cagin U; Fabregue J; Barral S; Moya-Nilges M; Krijnse-Locker J; van Wittenberghe L; Daniele N; Gjata B; Cosette J; Abad C; Simon-Sola M; Charles S; Li M; Crosariol M; Antrilli T; Quinn WJ; Gross DA; Boyer O; Anguela XM; Armour SM; Colella P; Ronzitti G; Mingozzi F
Nat Commun; 2021 Nov; 12(1):6393. PubMed ID: 34737297
[TBL] [Abstract][Full Text] [Related]
2. Gene Therapy for Pompe Disease: The Time is now.
Colella P; Mingozzi F
Hum Gene Ther; 2019 Oct; 30(10):1245-1262. PubMed ID: 31298581
[TBL] [Abstract][Full Text] [Related]
3. Rescue of Advanced Pompe Disease in Mice with Hepatic Expression of Secretable Acid α-Glucosidase.
Cagin U; Puzzo F; Gomez MJ; Moya-Nilges M; Sellier P; Abad C; Van Wittenberghe L; Daniele N; Guerchet N; Gjata B; Collaud F; Charles S; Sola MS; Boyer O; Krijnse-Locker J; Ronzitti G; Colella P; Mingozzi F
Mol Ther; 2020 Sep; 28(9):2056-2072. PubMed ID: 32526204
[TBL] [Abstract][Full Text] [Related]
4. Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid α-glucosidase.
Puzzo F; Colella P; Biferi MG; Bali D; Paulk NK; Vidal P; Collaud F; Simon-Sola M; Charles S; Hardet R; Leborgne C; Meliani A; Cohen-Tannoudji M; Astord S; Gjata B; Sellier P; van Wittenberghe L; Vignaud A; Boisgerault F; Barkats M; Laforet P; Kay MA; Koeberl DD; Ronzitti G; Mingozzi F
Sci Transl Med; 2017 Nov; 9(418):. PubMed ID: 29187643
[TBL] [Abstract][Full Text] [Related]
5. Muscle-specific, liver-detargeted adeno-associated virus gene therapy rescues Pompe phenotype in adult and neonate Gaa
Sellier P; Vidal P; Bertin B; Gicquel E; Bertil-Froidevaux E; Georger C; van Wittenberghe L; Miranda A; Daniele N; Richard I; Gross DA; Mingozzi F; Collaud F; Ronzitti G
J Inherit Metab Dis; 2024 Jan; 47(1):119-134. PubMed ID: 37204237
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy with secreted acid alpha-glucosidase rescues Pompe disease in a novel mouse model with early-onset spinal cord and respiratory defects.
Colella P; Sellier P; Gomez MJ; Biferi MG; Tanniou G; Guerchet N; Cohen-Tannoudji M; Moya-Nilges M; van Wittenberghe L; Daniele N; Gjata B; Krijnse-Locker J; Collaud F; Simon-Sola M; Charles S; Cagin U; Mingozzi F
EBioMedicine; 2020 Nov; 61():103052. PubMed ID: 33039711
[TBL] [Abstract][Full Text] [Related]
7. Immunodominant liver-specific expression suppresses transgene-directed immune responses in murine pompe disease.
Zhang P; Sun B; Osada T; Rodriguiz R; Yang XY; Luo X; Kemper AR; Clay TM; Koeberl DD
Hum Gene Ther; 2012 May; 23(5):460-72. PubMed ID: 22260439
[TBL] [Abstract][Full Text] [Related]
8. Improved efficacy of gene therapy approaches for Pompe disease using a new, immune-deficient GSD-II mouse model.
Xu F; Ding E; Liao SX; Migone F; Dai J; Schneider A; Serra D; Chen YT; Amalfitano A
Gene Ther; 2004 Nov; 11(21):1590-8. PubMed ID: 15356673
[TBL] [Abstract][Full Text] [Related]
9. Salmeterol enhances the cardiac response to gene therapy in Pompe disease.
Han SO; Li S; Koeberl DD
Mol Genet Metab; 2016 May; 118(1):35-40. PubMed ID: 27017193
[TBL] [Abstract][Full Text] [Related]
10. Enhanced efficacy of enzyme replacement therapy in Pompe disease through mannose-6-phosphate receptor expression in skeletal muscle.
Koeberl DD; Luo X; Sun B; McVie-Wylie A; Dai J; Li S; Banugaria SG; Chen YT; Bali DS
Mol Genet Metab; 2011 Jun; 103(2):107-12. PubMed ID: 21397538
[TBL] [Abstract][Full Text] [Related]
11. Pompe disease: from new views on pathophysiology to innovative therapeutic strategies.
Parenti G; Andria G
Curr Pharm Biotechnol; 2011 Jun; 12(6):902-15. PubMed ID: 21235442
[TBL] [Abstract][Full Text] [Related]
12. Enhanced efficacy from gene therapy in Pompe disease using coreceptor blockade.
Han SO; Li S; Brooks ED; Masat E; Leborgne C; Banugaria S; Bird A; Mingozzi F; Waldmann H; Koeberl D
Hum Gene Ther; 2015 Jan; 26(1):26-35. PubMed ID: 25382056
[TBL] [Abstract][Full Text] [Related]
13. Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune tolerance.
Sun B; Bird A; Young SP; Kishnani PS; Chen YT; Koeberl DD
Am J Hum Genet; 2007 Nov; 81(5):1042-9. PubMed ID: 17924344
[TBL] [Abstract][Full Text] [Related]
14. The pharmacological chaperone AT2220 increases recombinant human acid α-glucosidase uptake and glycogen reduction in a mouse model of Pompe disease.
Khanna R; Flanagan JJ; Feng J; Soska R; Frascella M; Pellegrino LJ; Lun Y; Guillen D; Lockhart DJ; Valenzano KJ
PLoS One; 2012; 7(7):e40776. PubMed ID: 22815812
[TBL] [Abstract][Full Text] [Related]
15. β2 Agonists enhance the efficacy of simultaneous enzyme replacement therapy in murine Pompe disease.
Koeberl DD; Li S; Dai J; Thurberg BL; Bali D; Kishnani PS
Mol Genet Metab; 2012 Feb; 105(2):221-7. PubMed ID: 22154081
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological Chaperone Therapy for Pompe Disease.
Borie-Guichot M; Tran ML; Génisson Y; Ballereau S; Dehoux C
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885805
[TBL] [Abstract][Full Text] [Related]
17. Synergistic Efficacy from Gene Therapy with Coreceptor Blockade and a β2-Agonist in Murine Pompe Disease.
Han SO; Li S; Bird A; Koeberl D
Hum Gene Ther; 2015 Nov; 26(11):743-50. PubMed ID: 26417913
[TBL] [Abstract][Full Text] [Related]
18. Reduction of Autophagic Accumulation in Pompe Disease Mouse Model Following Gene Therapy.
McCall AL; Stankov SG; Cowen G; Cloutier D; Zhang Z; Yang L; Clement N; Falk DJ; Byrne BJ
Curr Gene Ther; 2019; 19(3):197-207. PubMed ID: 31223086
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory, liver depot gene therapy for Pompe disease.
Bond JE; Kishnani PS; Koeberl DD
Cell Immunol; 2019 Aug; 342():103737. PubMed ID: 29295737
[TBL] [Abstract][Full Text] [Related]
20. Correction of glycogen storage disease type II by enzyme replacement with a recombinant human acid maltase produced by over-expression in a CHO-DHFR(neg) cell line.
Martiniuk F; Chen A; Donnabella V; Arvanitopoulos E; Slonim AE; Raben N; Plotz P; Rom WN
Biochem Biophys Res Commun; 2000 Oct; 276(3):917-23. PubMed ID: 11027569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
